Wegovy Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

Novo Nordisk and Hims & Hers Bury the Hatchet and Partner to Expand Access to Ozempic, Wegovy

Wegovy HD Receives FDA Approval as Fourth Product Under National Priority Voucher Program

Ozempic Lawsuits Continue With Second US Mass Litigation Involving GLP-1 Drugs and Vision Loss

December 19, 2025

Top 3 Best-Selling Weight-Loss Drugs to Watch in 2025

September 10, 2025

Top 50 Best-Selling Drugs to Watch in 2025: Insights from 2024 Sales Data

Hims & Hers Pairs Up with Novo Nordisk to Offer Discounted Wegovy, After Previous Feud

CagriSema, Novo Nordisk’s Latest Obesity Drug Offering, Disappoints Investors with Trial Results

Zepbound Versus Wegovy: Head-to-Head Trial Reveals Which Has the Weight Loss Edge

December 6, 2024

Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight

November 15, 2024

GLP-1 Drugs Mounjaro, Zepbound, Wegovy Back in Stock After Extended Shortages

August 22, 2024

Novo Nordisk Launches ‘Power of Wegovy’ National Campaign to Educate and Empower

Healthcare News

Vital Pursuit: Nestlé’s New Food Line for Weight Management

Real Chemistry Introduces IRIS, an Information Hub for All Things GLP-1 Drugs

Bernie Sanders Launches Investigation into the “Outrageously High” Prices of Ozempic and Wegovy, Making Them “Luxury Goods”

Oprah Hosts TV Special About GLP-1 Drugs for Weight Loss

Eli Lilly’s Oscars Commercial Takes Aim at Hollywood’s Use of Obesity Medicines for ‘Vanity’

Next Page »